A detailed history of First Trust Advisors LP transactions in Organon & Co. stock. As of the latest transaction made, First Trust Advisors LP holds 1,638,751 shares of OGN stock, worth $23.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,638,751
Previous 1,274,977 28.53%
Holding current value
$23.9 Million
Previous $26.4 Million 18.78%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$18.65 - $23.03 $6.78 Million - $8.38 Million
363,774 Added 28.53%
1,638,751 $31.3 Million
Q2 2024

Aug 13, 2024

BUY
$17.45 - $21.96 $5.61 Million - $7.06 Million
321,685 Added 33.74%
1,274,977 $26.4 Million
Q1 2024

May 13, 2024

SELL
$13.78 - $18.8 $1.58 Million - $2.16 Million
-114,832 Reduced 10.75%
953,292 $17.9 Million
Q4 2023

Feb 13, 2024

BUY
$10.95 - $17.32 $3.85 Million - $6.09 Million
351,518 Added 49.05%
1,068,124 $15.4 Million
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $3.52 Million - $5.04 Million
-211,904 Reduced 22.82%
716,606 $12.4 Million
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $1.76 Million - $2.25 Million
91,176 Added 10.89%
928,510 $19.3 Million
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $1.93 Million - $2.9 Million
-90,270 Reduced 9.73%
837,334 $19.7 Million
Q4 2022

Feb 09, 2023

BUY
$23.31 - $28.61 $5.42 Million - $6.66 Million
232,703 Added 33.49%
927,604 $25.9 Million
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $15.4 Million - $22.5 Million
-657,690 Reduced 48.62%
694,901 $16.3 Million
Q2 2022

Aug 12, 2022

BUY
$31.66 - $38.9 $7.34 Million - $9.02 Million
231,835 Added 20.69%
1,352,591 $45.7 Million
Q1 2022

May 13, 2022

BUY
$30.45 - $39.36 $13.9 Million - $18 Million
456,966 Added 68.84%
1,120,756 $39.1 Million
Q4 2021

Feb 08, 2022

BUY
$28.67 - $37.13 $19 Million - $24.6 Million
663,790 New
663,790 $20.2 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.71B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.